Cboe UK EUR

thyssenkrupp nucera AG & Co. KGaA (NCH2D.XC)

Compare
9.44
0.00
(0.00%)
As of June 26 at 3:22:08 PM GMT+1. Market Open.
Loading Chart for NCH2D.XC
  • Previous Close 9.44
  • Open 9.44
  • Bid 9.80 x --
  • Ask 9.39 x --
  • Day's Range 9.44 - 9.44
  • 52 Week Range 9.44 - 16.27
  • Volume 108
  • Avg. Volume 0
  • Market Cap (intraday) 1.192B
  • Beta (5Y Monthly) --
  • PE Ratio (TTM) 188.80
  • EPS (TTM) 0.05
  • Earnings Date --
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

thyssenkrupp nucera AG & Co. KGaA engages in the development, engineering, procurement, commissioning, and licensing of high-performance electrolysis technologies in Germany, Italy, the Middle East, Africa, South America, Asia, and internationally. The company offers green hydrogen, chlor- alkali, and hydrochloric acid solutions. It serves chemical and steel industries, as well as refineries. The company was formerly known as thyssenkrupp Uhde Chlorine Engineers GmbH. The company was founded in 1960 and is headquartered in Dortmund, Germany. thyssenkrupp nucera AG & Co. KGaA operates as a subsidiary of Thyssenkrupp Projekt 1 GmbH.

thyssenkrupp-nucera.com

1,059

Full Time Employees

September 30

Fiscal Year Ends

Recent News: NCH2D.XC

View More

Performance Overview: NCH2D.XC

Trailing total returns as of 4/7/2025, which may include dividends or other distributions. Benchmark is DAX P (^GDAXI) .

YTD Return

NCH2D.XC
0.00%
DAX P (^GDAXI)
1.16%

1-Year Return

NCH2D.XC
41.98%
DAX P (^GDAXI)
10.81%

3-Year Return

NCH2D.XC
57.09%
DAX P (^GDAXI)
43.06%

5-Year Return

NCH2D.XC
57.09%
DAX P (^GDAXI)
94.46%

Compare To: NCH2D.XC

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: NCH2D.XC

View More

Valuation Measures

Annual
As of 4/4/2025
  • Market Cap

    1.01B

  • Enterprise Value

    325.68M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    --

  • Price/Book (mrq)

    --

  • Enterprise Value/Revenue

    --

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    1.96%

  • Return on Assets (ttm)

    -0.55%

  • Return on Equity (ttm)

    2.39%

  • Revenue (ttm)

    918M

  • Net Income Avi to Common (ttm)

    18M

  • Diluted EPS (ttm)

    0.05

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    709M

  • Total Debt/Equity (mrq)

    3.40%

  • Levered Free Cash Flow (ttm)

    -78.7M

Research Analysis: NCH2D.XC

View More

Company Insights: NCH2D.XC

Research Reports: NCH2D.XC

View More